Journal article
Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer
N Ahmed, A Latifi, CB Riley, JK Findlay, MA Quinn
Journal of Ovarian Research | BMC | Published : 2010
Abstract
Objectives: In view of the recent association of Brn-3 transcription factors with neuroblastomas, cervical, breast, and prostate cancers we examined the expression of Brn-3a(l) in normal ovaries and in different histological grades of ovarian tumors. The expression of Brn-3a(l) was also evaluated in normal ovarian and cancer cell lines and tumor cells isolated from the ascites of advanced-stage ovarian cancer patients. Methods: Normal ovaries, benign, borderline, grades 1, 2 and 3 ovarian tumors were analyzed by immunohistochemistry for Brn-3a(l) expression. A total of 46 ovarian specimens were included in the study. Immunofluorescence was used to investigate the expression of Brn-3a in norm..
View full abstractGrants
Awarded by Foundation for Women's Cancer
Funding Acknowledgements
The authors wish to thank Royal Women's Hospital Foundation (Liz's Fund), Women's Cancer Foundation and the National Health and Medical Research Council of Australia (JKF, RegKey#441101) for supporting this work. AL is the recipient of Royal Women's Hospital, postgraduate scholarship. The author's acknowledge Dr Natalie Castrechini's assistance in preparing the immunohistochemistry images.